Investment Of Rs 200 Cr For Medicinal Plant Sector Of NE: Sonowal

Jorhat: Union minister Sarbananda Sonowal on Sunday said investment to the tune of around Rs 200 crore will be made in the CSIR-North East Institute of Science and Technology (NEIST) to build capacity for the medicinal plant sector of the region.

The amount is aimed at creating infrastructure that will boost medicinal plant storage for commercial purpose, strengthen research and development of local herbs and plants for medicinal purpose, as well as provide a platform for traditional healers to further their treatment to a wider section of the society, an official release said.

Sonowal, the Union Minister of Ayush, made the announcement at CSIR-NEIST.

The NEIST at Jorhat, formerly known as Regional Research Laboratory, is a constituent establishment of the Council of Scientific and Industrial Research (CSIR).

“The rich bounty of nature of North East must be used responsibly so that the ecology of the region is sustained, while the medicinal benefits from the herbs can be extracted responsibly to ramp up India’s rich heritage in traditional medicine,” Sonowal said.

“We are revitalising the traditional medicine with a rational approach to scientifically validate its outcome so that more and more people can avail its life-enriching benefit. As India leads the resurgence of traditional medicine globally, the North East will play a crucial role to act as harbinger of growth for the healing industry of India,” he said.

During the visit, the minister reviewed the progress of different activities undertaken by the institute to strengthen the potential of medicinal plant market in the region, the release added.

Related Posts

  • Pharma
  • July 26, 2024
  • 110 views
US FDA Finds Data Integrity, Sterility Problems At Brassica Pharma

Maryland: The US Food and Drug Administration (FDA) has warned Brassica Pharma for numerous good manufacturing practice (GMP) violations, including multiple instances of employees falsifying sterility and environmental monitoring data and…

  • Pharma
  • July 26, 2024
  • 105 views
Indian National Charged With Selling Counterfeit Cancer Drugs

HOUSTON: A federal grand jury has returned an indictment charging an Indian national with selling and shipping tens of thousands of dollars in counterfeit oncology pharmaceuticals into the United States,…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

US FDA Finds Data Integrity, Sterility Problems At Brassica Pharma

US FDA Finds Data Integrity, Sterility Problems At Brassica Pharma

Indian National Charged With Selling Counterfeit Cancer Drugs

Indian National Charged With Selling Counterfeit Cancer Drugs

ICMR Releases 32 New Treatment Standards For Treating Common And Serious Diseases

ICMR Releases 32 New Treatment Standards For Treating Common And Serious Diseases

BIS Sanctioned 82 Medical Device Projects To Develop Standards

BIS Sanctioned 82 Medical Device Projects To Develop Standards

Anti-Narcotics Task Force Will Be Formed Soon In Rajasthan: HM

Anti-Narcotics Task Force Will Be Formed Soon In Rajasthan: HM

‘Sunrise’ MedTech Industry in India & ‘Clouds’ strangling it, Brainstormed in PHD

‘Sunrise’ MedTech Industry in India & ‘Clouds’ strangling it, Brainstormed in PHD